Novel Anticoagulants: Evidence-Based Patient Selection

Decisions, decisions: a direct thrombin inhibitor or a factor Xa inhibitor for management of non-valvular AF? Each is a good choice for a specific patient type. Here, how to choose among them.
Source: Consultant Live - Category: Primary Care Source Type: news
More News: Primary Care